OBT vs BCAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

OBT

54.8
AI Score
VS
OBT Wins

BCAL

50.2
AI Score

Investment Advisor Scores

OBT

55score
Recommendation
HOLD

BCAL

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OBT BCAL Winner
Net Income 11.28M 13.79M BCAL
ROE 3.9% 2.4% OBT
ROA 0.4% 0.3% OBT
Total Assets 2.71B 4.05B BCAL
Free Cash Flow 9.67M 8.30M OBT

Relative Price Performance (Last 90 Days)

OBT 1M: +1.6% · 3M: +12.2% BCAL 1M: +0.6% · 3M: +14.0%

Current Technical Phase

OBT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 58

RSI (14): 57.6 · Price: $38.25

BCAL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 58

RSI (14): 57.9 · Price: $21.30

Fundamentals Snapshot

Metric OBT BCAL
Market Cap
Forward P/E 10.0 11.5
Trailing P/E 10.7 11.7
Revenue (TTM)
Revenue Growth -0.1% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.5%
EPS 3.52 1.81
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, OBT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.